BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32914016)

  • 1. Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology Program.
    Poonnen PJ; Duffy JE; Hintze B; Shukla M; Brettin TS; Conrad NR; Yoo H; Guertin C; Looney JA; Vashistha V; Kelley MJ; Spector NL
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program.
    Doerstling S; Winski D; Katsoulakis E; Agarwal P; Poonnen PJ; Snowdon JL; Jackson GP; Weeraratne D; Kelley MJ; Vashistha V
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):69-77. PubMed ID: 36117189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
    Vashistha V; Armstrong J; Winski D; Poonnen PJ; Hintze B; Price M; Snowdon JL; Weeraratne D; Brotman D; Jackson GP; Kelley MJ
    JCO Oncol Pract; 2021 Jul; 17(7):e1012-e1020. PubMed ID: 33780286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program.
    Katsoulakis E; Duffy JE; Hintze B; Spector NL; Kelley MJ
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Availability of healthcare providers for rural veterans eligible for purchased care under the veterans choice act".
    Ohl ME; Carrell M; Thurman A; Weg MV; Hudson T; Mengeling M; Vaughan-Sarrazin M
    BMC Health Serv Res; 2018 May; 18(1):315. PubMed ID: 29807536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
    Vashistha V; Poonnen PJ; Snowdon JL; Skinner HG; McCaffrey V; Spector NL; Hintze B; Duffy JE; Weeraratne D; Jackson GP; Kelley MJ; Patel VL
    PLoS One; 2020; 15(7):e0235861. PubMed ID: 32706774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted mutation detection in breast cancer using MammaSeq™.
    Smith NG; Gyanchandani R; Shah OS; Gurda GT; Lucas PC; Hartmaier RJ; Brufsky AM; Puhalla S; Bahreini A; Kota K; Wald AI; Nikiforov YE; Nikiforova MN; Oesterreich S; Lee AV
    Breast Cancer Res; 2019 Feb; 21(1):22. PubMed ID: 30736836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Advancing" Advance Care Planning to Veterans in the Veterans Health Administration.
    Matthieu MM; Ounpraseuth ST; Williams JS; Hu B; Adkins DA; Taylor LD; Oliver CM; Smith RM; Painter JT; McCullough JA; Garner KK
    Mil Med; 2023 Mar; 188(3-4):786-791. PubMed ID: 35801841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
    Hernandez KM; Venkat A; Elbers DC; Bihn JR; Brophy MT; Do NV; La J; Liu Q; Prokhorenkov A; Metoki-Shlubsky N; Sung FC; Paller CJ; Fillmore NR; Grossman RL
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 38050021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now.
    Scott A; Mohan A; Austin S; Amini E; Raupp S; Pannecouk B; Kelley MJ; Narla G; Ramnath N
    JCO Oncol Pract; 2022 Jun; 18(6):e966-e973. PubMed ID: 35258993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
    Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL
    Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study.
    Hall RK; Wang V; Jackson GL; Hammill BG; Maciejewski ML; Yano EM; Svetkey LP; Patel UD
    BMC Med Inform Decis Mak; 2012 Jul; 12():69. PubMed ID: 22788730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs.
    Belperio PS; Mole LX; Boothroyd DB; Backus LI
    J Manag Care Pharm; 2009 May; 15(4):323-34. PubMed ID: 19422272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Research Engagement and Priorities of Transgender and Gender Diverse Veterans.
    Wolfe HL; Boyer TL; Rodriguez KL; Klima GJ; Shipherd JC; Kauth MR; Blosnich JR
    Mil Med; 2023 May; 188(5-6):e1224-e1231. PubMed ID: 34791410
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.